This analysis was controlled for age at diagnosis, breast cancer subtype, treatment (chemotherapy-only (chemo-only) versus all other treatments), and the interaction between TGFB2 by Gene2 for 786 evaluable patients. This evidence concerns the gene TGFB2 and breast carcinoma.